Axelle Loriot

4PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 02, 2023
Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111-24111).

Simon P Beyaert, Axelle E Loriot, Nicolas D Huyghe

|Jul 05, 2023
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1.

Alexandra L Degraeve, Vincent Haufroid, Axelle Loriot

|Oct 31, 2020
PAR-TERRA is the main contributor to telomeric repeat-containing RNA transcripts in normal and cancer mouse cells.

Nikenza Viceconte, Axelle Loriot, PatrĂ­cia Lona Abreu

Pageof 1